CSI Market
Sign In | Register

Teva Pharmaceutical Industries Limited (TEVA) Annual Balance Sheets

Annual · GAAP · USD millions
Access TEVA quarterly Balance Sheets →
Quarterly balance sheet trends provide context on Teva Pharmaceutical Industries Limited's liquidity, leverage, and long-term financial structure.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent3,556.00
Cash, Cash Equivalents Other0.00
Cash & Short-term Investments3,556.00
Accounts receivable3,709.00
Inventories1,904.00
Derivatives, Collateral, Regulatory, Deferred0.00
Disposal Group, Including Discontinued Operation, Assets, Current AS1,842.00
Other Current Assets538.00
Prepaid Expense, Current AS1,122.00
Total Current Assets13,946.00
Equipment/Property/Plant Net4,080.00
Goodwill net16,000.00
Intangible Assets13,330.00
Deferred Tax Assets, Net of Valuation Allowance, Noncurrent2,191.00
Deferred, Prepaid and Other Assets, Noncurrent66.00
Discontinued operations, Noncurrent184.00
Other Assets, Noncurrent2,941.00
Total Assets40,748.00
Liabilities
Accounts Payable, Trade, Current2,531.00
Employee-related Liabilities, Current AC739.00
Debt, Current LI1,820.00
Other Liabilities, Current8,366.00
Taxes Payable596.00
Discontinued Operation, Liabilities16.00
Total Current Liabilities13,456.00
Long-term debt14,986.00
Capital Lease and Other0.00
Total Long-term Debt14,986.00
Financial Instruments, Insurance, Noncurrent138.00
Deferred Tax Liabilities, Net, Noncurrent LI296.00
Discontinued Operation, Noncurrent261.00
Other liabilities, Noncurrent4,392.00
Sales Reserves And Allowances4,143.00
Accrued Expenses2,687.00
Total Liabilities32,834.00
Stockholders' Equity
Common Stock Value58.00
Treasury Stock Value4,128.00
Additional Paid In Capital Common Stock28,133.00
Retained Earnings / Accumulated Deficit-13,762.00
Accumulated Other Comprehensive Income-2,391.00
Other Equity-2,391.00
Common Stockholder's Equity7,910.00
Non-controlling interests & other4.00
Total Stockholder's Equity7,910.00
Liabilities & Stockholder's Equity40,748.00
4 historic quarters locked

Sign in to unlock the full Teva Pharmaceutical Industries Limited balance sheet history.

Sign In Create Free Account

About Teva Pharmaceutical Industries Ltd Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 3, 2026
  • Source: d93612d10k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-034532

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License